EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive License Agreement to Advance Ex Vivo Engineered Cell Therapy Programs
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies…
Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion